Mizerska-Wasiak Małgorzata, Winiarska Maria, Nogal Karolina, Cichoń-Kawa Karolina, Pańczyk-Tomaszewska Małgorzata, Małdyk Jadwiga
Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Student's Scientific Group at the Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Pediatr Rep. 2021 Jul 22;13(3):416-420. doi: 10.3390/pediatric13030048.
Immunoglobulin A (IgA) vasculitis is the most common systemic vasculitis in the pediatric population. We present the case of a patient with IgA vasculitis with nephritis who developed cytomegalovirus (CMV) infection followed by Mycobacterium tuberculosis infection. In the literature, there are a few cases of IgA nephropathy accompanied by reactivation of CMV or tuberculosis. To the best of our knowledge, this is the first reported case of IgA vasculitis complicated by both CMV reactivation and tuberculosis. It is important to detect infections in patients with IgA vasculitis because they can induce and exacerbate the symptoms of the disease. Effective antimicrobial treatment facilitates the management of proteinuria and slows down the decline of renal function. Immunosuppressive therapy is a risk factor for reactivation of latent infections and makes patients more susceptible to its generalized and complicated course. This can be prevented by actively screening for hidden sites of infection.
免疫球蛋白A(IgA)血管炎是儿科人群中最常见的系统性血管炎。我们报告了一例患有IgA血管炎伴肾炎的患者,该患者先后发生了巨细胞病毒(CMV)感染和结核分枝杆菌感染。在文献中,有少数IgA肾病伴有CMV或结核再激活的病例。据我们所知,这是首例报告的IgA血管炎并发CMV再激活和结核的病例。在IgA血管炎患者中检测感染很重要,因为感染可诱发和加重疾病症状。有效的抗菌治疗有助于蛋白尿的管理,并减缓肾功能下降。免疫抑制治疗是潜伏感染再激活的危险因素,会使患者更易发生全身性和复杂性病程。通过积极筛查感染隐匿部位可预防这种情况。